141 related articles for article (PubMed ID: 36519609)
21. Predictive value of the hemoglobin-albumin-lymphocyte-platelet (HALP) index for ICU mortality in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Han H; Hu S; Du J
Intern Emerg Med; 2023 Jan; 18(1):85-96. PubMed ID: 36357607
[TBL] [Abstract][Full Text] [Related]
22. Early changes of platelet‑lymphocyte ratio correlate with neoadjuvant chemotherapy response and predict pathological complete response in breast cancer.
Dan J; Tan J; Huang J; Yuan Z; Guo Y
Mol Clin Oncol; 2023 Nov; 19(5):90. PubMed ID: 37854328
[TBL] [Abstract][Full Text] [Related]
23. Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis.
Zhou Q; Dong J; Sun Q; Lu N; Pan Y; Han X
BMJ Open; 2021 Sep; 11(9):e047957. PubMed ID: 34561257
[TBL] [Abstract][Full Text] [Related]
24. Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis.
Njoku K; Barr CE; Ramchander NC; Crosbie EJ
PLoS One; 2022; 17(8):e0272232. PubMed ID: 35925991
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of hemoglobin, albumin, lymphocyte, and platelet indexes in predicting lymph node metastasis and recurrence of endometrial cancer: a retrospective study.
Xiong Y; Yong Y; Wang Y
PeerJ; 2023; 11():e16043. PubMed ID: 37786581
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of hemoglobin, albumin, lymphocyte, platelet in gastrointestinal stromal tumors: A propensity matched retrospective cohort study.
Zhao Z; Yin XN; Wang J; Chen X; Cai ZL; Zhang B
World J Gastroenterol; 2022 Jul; 28(27):3476-3487. PubMed ID: 36158264
[TBL] [Abstract][Full Text] [Related]
27. Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
Chatterjee D; Bal A; Das A; Singh G
Virchows Arch; 2015 Sep; 467(3):303-10. PubMed ID: 26063415
[TBL] [Abstract][Full Text] [Related]
28. Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study.
Sarradin V; Lusque A; Filleron T; Dalenc F; Franchet C
Breast Cancer Res; 2021 May; 23(1):61. PubMed ID: 34039396
[TBL] [Abstract][Full Text] [Related]
29. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel prognostic factor for patients with diffuse large B-cell lymphoma.
Vlatka P; Marko L; Stefan M; Dorian L
J Cancer Res Ther; 2022; 18(3):725-732. PubMed ID: 35900546
[TBL] [Abstract][Full Text] [Related]
30. Practical parameters that can be used for nutritional assessment in patients hospitalized in the intensive care unit with the diagnosis of chronic obstructive pulmonary disease: Prognostic nutritional index, neutrophil-to-lymphocyte, platelet-to-lymphocyte, and lymphocyte-to-monocyte ratio.
Baldemir R; Cirik MÖ
Medicine (Baltimore); 2022 Jun; 101(24):e29433. PubMed ID: 35713452
[TBL] [Abstract][Full Text] [Related]
31. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Jiang C; Zhang S; Qiao K; Xiu Y; Yu X; Huang Y
Clin Breast Cancer; 2022 Jul; 22(5):424-438. PubMed ID: 35428593
[TBL] [Abstract][Full Text] [Related]
32. Association of immune inflammatory biomarkers with pathological complete response and clinical prognosis in young breast cancer patients undergoing neoadjuvant chemotherapy.
Li F; Wang Y; Dou H; Chen X; Wang J; Xiao M
Front Oncol; 2024; 14():1349021. PubMed ID: 38380360
[TBL] [Abstract][Full Text] [Related]
33. Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: The Role of Immune-related Factors.
Palaia I; Tomao F; DI Pinto A; Pernazza A; Santangelo G; D'Alessandris N; Manganaro L; Arno A; Donato VD; Perniola G; Della Rocca C; Panici PB
In Vivo; 2021; 35(2):1277-1283. PubMed ID: 33622931
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
[TBL] [Abstract][Full Text] [Related]
35. EarlyR signature predicts response to neoadjuvant chemotherapy in breast cancer.
Buechler SA; Gökmen-Polar Y; Badve SS
Breast; 2019 Feb; 43():74-80. PubMed ID: 30502641
[TBL] [Abstract][Full Text] [Related]
36. Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study.
Tang L; Shu X; Tu G
World J Surg Oncol; 2022 Jan; 20(1):27. PubMed ID: 35093083
[TBL] [Abstract][Full Text] [Related]
37. The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB).
Fayanju OM; Ren Y; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Tamirisa N; Force J; Boughey JC; Hyslop T; Hwang ES
Ann Surg; 2018 Oct; 268(4):591-601. PubMed ID: 30048319
[TBL] [Abstract][Full Text] [Related]
38. Importance of HALP Score in Breast Cancer and its Diagnostic Value in Predicting Axillary Lymph Node Status.
Duran A; Pulat H; Cay F; Topal U
J Coll Physicians Surg Pak; 2022 Jun; 32(6):734-739. PubMed ID: 35686404
[TBL] [Abstract][Full Text] [Related]
39. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
40. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
